Curis | CRIS - Cost Of Sales


Curis reported $314K in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Alaunos Therapeutics USD 0 18K Sep/2024
Amgen USD 1.6B 187M Mar/2026
AstraZeneca USD -204M 3.48B Mar/2026
Bayer EUR 5.23B 731M Mar/2026
Bristol-Myers Squibb USD 3.86B 1.07B Mar/2026
CSL USD 3.87B 2.08B Dec/2025
Curis USD 314K 9.96M Dec/2025
Eli Lilly USD 3.58B 205M Mar/2026
Exelixis USD 19.95M 6.53M Mar/2026
Gilead Sciences USD 1.44B 174M Mar/2026
GlaxoSmithKline GBP 1.88B 736M Mar/2026
Incyte USD 104.5M 16.68M Mar/2026
Merck USD 2.94B 380M Mar/2026
Novartis USD 3.46B 83M Mar/2026
Pfizer USD 4.59B 1.7B Mar/2026
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 3.67B 621M Mar/2026
Takeda JPY 560.54B 159.39B Mar/2026
TG Therapeutics USD 33.51M 4.63M Mar/2026
Verastem USD 2.89M 2.88M Dec/2025
Xoma 116K 112.7K Jun/2024